Cohen Announces $167K in New Federal Funds for Memphis Medical Research Company

WASHINGTON, D.C. – Congressman Steve Cohen (D-TN-9) today announced a Memphis medical research company – Translational Sciences Inc. – has been awarded $167,685 from the National Heart, Lung and Blood Institute (NHLBI) for research into novel methods for dissolving blood clots.

“Memphis has some of the best medical research companies in the country,” said Congressman Cohen. “These federal funds will be used to conduct research that will hopefully save lives across Memphis and the country.”

Translational Sciences Inc., a medical research laboratory, is currently conducting research into blood diseases, particularly novel methods that prevent bleeding and clotting. NHLBI is a division of the National Institutes of Health that conducts research, training, and education programs to promote the prevention and treatment of heart, lung and blood diseases.